PrEP, Female, Injectable Monitor (No HIV RNA)
Also known as: HIV, PrEP, Prophylaxis
Use
This profile aligns with current guidelines for monitoring female patients on injectable HIV PrEP.
Special Instructions
Not provided.
Limitations
HIV p24 antigen/antibody specimens with reactive results must be confirmed with additional supplemental tests. Negative test results do not preclude exposure to or infection with HIV-1 and/or HIV-2, as the quantity of the marker may be too low for detection or not present during the stage of disease when collected. Biotin supplementation can interfere with test results, making it important to ensure patients stop taking it prior to sample collection.
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 004417
- 019054
- 082356
- 083936
- 188078
- 188086
- 56888-1 - HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA
- 47236-5 - T palldm IgG+IgM SerPl Ql IA
- 43304-5 - C trach rRNA Spec Ql NAA+probe
- 43305-2 - N gonorrhoea rRNA Spec Ql NAA+probe
- 11502-2 - Laboratory report
- 45194-8 - HCG Intact+B SerPl-aCnc
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
4 mL
Container
Gel-barrier tube
Collection Instructions
Usual blood collection technique.
Patient Preparation
Patient should not have urinated for one hour prior to specimen collection.
Storage Instructions
Refrigerated up to 7 days
Causes for Rejection
Hemolysis; lipemia; received outside of specimen and/or storage and/or labeling requirements; aliquot received for HIV testing; specimen in expired transport or incorrect transport device.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 7 days |
| Frozen | 6 weeks |
Other tests from different labs that may be relevant